
    
      This is a multicenter study of ceftaroline fosamil in elderly subjects (â‰¥ 65 years of age)
      with CABP. Adjunctive macrolide therapy is to be used at the Investigator's discretion. A
      switch to oral treatment may be allowed at the discretion of the Investigator. The total
      duration of therapy is 5 to 7 days; a minimum of 48 hours of study drug is required.
    
  